The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T‐cell lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|7-1048|2|215-226

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.7-1048, Iss.2, 2015-10, pp. : 215-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T‐cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 215-226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Entinostat, a novel histone deacetylase inhibitor is active in B‐cell lymphoma and enhances the anti‐tumour activity of rituximab and chemotherapy agents

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 506-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitors

By                    

International Journal of Molecular Medicine, Vol. 29, Iss. 2, 2012-01 ,pp. : 218-224

Spandidos Publications

Access to resources Recommend Favorite

Successful Treatment of Adult T‐cell Leukemia/Lymphoma with MACOP‐B, M‐FEPA and VEPP‐B Combination Chemotherapy

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 10, 1993-10 ,pp. : 623-629

John Wiley & Sons Inc

Access to resources Recommend Favorite

T-cell lymphoma manifesting as a uvular mass

By Lai Wen-Sen  

British Journal of Rheumatology , Vol. 52, Iss. 4, 2013-04 ,pp. : 608-608

Oxford University Press

Access to resources Recommend Favorite